ICL 670: effective oral iron chelation therapy

By  

Inpharma, Vol. 1, Iss. 1376, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The desferrithiocin (DFT) class of iron chelators: potential as antineoplastic agents

By Kicic A.   Chua A.C.G.   Baker E.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 195-207

Cognizant Communication Corporation

Access to resources Recommend Favorite

Advances in Iron Overload Therapies. Prospects for Effective Use of Deferiprone (L1), Deferoxamine, the New Experimental Chelators ICL670, GT56-252, L1NAll and their Combinations

By  

Current Medicinal Chemistry, Vol. 12, Iss. 23, 2005-11 ,pp. : 2663-2681

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload

By Cappellini MD   Taher A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2391-2402

Informa Healthcare

Access to resources Recommend Favorite

Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity

By  

Current Drug Delivery, Vol. 7, Iss. 3, 2010-07 ,pp. : 194-207

Bentham Science Publishers

Access to resources Recommend Favorite